Monday, 29 April 2019

Researchers continue efforts to lower drug-resistant hypertension without medication

The Emory Heart & Vascular Center is participating in an FDA-approved pivotal trial, called CALM-2 (Controlling And Lowering blood pressure with MobiusHDÒ), of a novel catheter-based, non-surgical procedure to treat patients with drug-resistant hypertension.

* This article was originally published here